SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 95.91 |
| Enterprise Value ($M) | 152.45 |
| Book Value ($M) | -86.61 |
| Book Value / Share | -0.77 |
| Price / Book | -1.11 |
| NCAV ($M) | -89.00 |
| NCAV / Share | -0.79 |
| Price / NCAV | -1.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.79 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.55 |
| Current Ratio | 0.60 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 105.33 |
| Assets | 107.73 |
| Liabilities | 194.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 70.99 |
| Operating Income | -22.75 |
| Net Income | -35.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -20.53 |
| Cash from Investing | -0.33 |
| Cash from Financing | 0.30 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rosalind Advisors, Inc. | 5.14 | -7.04 | |
| 13G/A | Great Point Partners Llc | 9.99 | 1.50 | |
| 13G/A | Acorn Bioventures, L.p. | 9.90 | 5.92 | |
| 13G/A | Fmr Llc | 14.68 | 14.59 | |
| 13G/A | Kruttschnitt Theodore H Iii | 7.98 | 5.49 | |
| 13G/A | Avista Capital Partners II GP, LLC | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| , 202 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,001,250 | 526,988 | 189.99 | |
| 6,077,578 | 2,512,803 | 241.86 | |
| 202,975 | 105,402 | 192.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OLMA – Olema Pharmaceuticals, Inc. | OMGA – Omega Therapeutics, Inc. |
| OPK – OPKO Health, Inc. | ORIC – ORIC Pharmaceuticals, Inc. |
| OVID – Ovid Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io